PhaseRx (PZRX) is Initiated by ROTH Capital to Buy, Price Target at $8

PhaseRx (PZRX) was Initiated by ROTH Capital to “Buy” and the brokerage firm has set the Price Target at $8. ROTH Capital advised their investors in a research report released on Jun 17, 2016.


Leave a Reply

PhaseRx - Is it time to Sell?

Top Brokerage Firms are advising their investors on PhaseRx. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.